Maria Juncal-Ruiz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Maria Juncal-Ruiz has a total of 61 co-authors. Here are the top co-authors by number of shared publications:
- Víctor Ortiz-García de la Foz
Instituto de Investigación Marqués de Valdecilla
6 shared publications - Javier Vázquez-Bourgon
Department of Psychiatry, Marqués de Valdecilla University Hospital, IDIVAL, School of Medicine, University of Cantabria, Santander, Spain
5 shared publications Benedicto Crespo-Facorro
Department of Psychiatry, Virgen del Rocío University Hospital, School of Medicine, University of Sevilla, IBiS, CIBERSAM, CSIC, Av. Manuel Siurot s/n, 41013, Sevilla, Spain
3 shared publications- Benedicto Crespo-Facorro
Translational Psychiatry Group, Institute of Biomedicine of Seville (IBiS), Seville, Spain
3 shared publications - Benedicto Crespo-Facorro
University of Cantabria
3 shared publications - Esther Setién-Suero
Department of Psychiatry, School of Medicine, University of Cantabria, University Hospital Marqués de Valdecilla, Santander, Spain
3 shared publications
Latest Publications
- Open Access
- 31 January 2025
- Published by Springer Nature in Journal of Autism and Developmental Disorders
- Vol. 56 (6) , 2136-2147
What Predicts Early Math in Autism? A Study of Cognitive and Linguistic Factors
This study aimed to examine early mathematical abilities in young children with autism aged four to seven without intellectual disabilities and their connection with autism severity, non-verbal intelligence, and linguistic abilities (receptive vocabulary and grammar). The study involved 42 children with autism. We assessed participants’ cognitive, mathematical, and linguistic abilities. Their mathematical performance was compared with that of typically developing children using standardized measures. Statistical analyses were conducted to identify potential cognitive or linguistic differences across groups based on mathematical performance, and to determine predictive factors for mathematical abilities in children with autism. The findings indicated a higher prevalence of mathematical difficulties among the participants compared to typically developing children. A classification based on mathematical performance revealed statistically significant differences in cognitive and linguistic variables across groups, particularly in the low-performance group. However, no significant differences were found according to autism severity between the groups. The analysis further identified that a combination of visuo-spatial and linguistic abilities was the most predictive factor for mathematical performance. The study suggests that young children with autism without intellectual disabilities may be more likely to experience mathematical difficulties compared to typically developing children. Assessing cognitive and linguistic abilities could serve as a predictive measure for mathematical difficulties of children with autism, even without a formal diagnosis. Future research, with larger samples or longitudinal approaches, could validate these findings or explore which specific mathematical abilities are more related to non-verbal intelligence and which ones to structural language.
- 31 January 2025
- Published by Springer Nature in Journal of Autism and Developmental Disorders
- Vol. 56 (6) , 2136-2147
Open AccessWhat Predicts Early Math in Autism? A Study of Cognitive and Linguistic Factors
This study aimed to examine early mathematical abilities in young children with autism aged four to seven without intellectual disabilities and their connection with autism severity, non-verbal intelligence, and linguistic abilities (receptive vocabulary and grammar). The study involved 42 children with autism. We assessed participants’ cognitive, mathematical, and linguistic abilities. Their mathematical performance was compared with that of typically developing children using standardized measures. Statistical analyses were conducted to identify potential cognitive or linguistic differences across groups based on mathematical performance, and to determine predictive factors for mathematical abilities in children with autism. The findings indicated a higher prevalence of mathematical difficulties among the participants compared to typically developing children. A classification based on mathematical performance revealed statistically significant differences in cognitive and linguistic variables across groups, particularly in the low-performance group. However, no significant differences were found according to autism severity between the groups. The analysis further identified that a combination of visuo-spatial and linguistic abilities was the most predictive factor for mathematical performance. The study suggests that young children with autism without intellectual disabilities may be more likely to experience mathematical difficulties compared to typically developing children. Assessing cognitive and linguistic abilities could serve as a predictive measure for mathematical difficulties of children with autism, even without a formal diagnosis. Future research, with larger samples or longitudinal approaches, could validate these findings or explore which specific mathematical abilities are more related to non-verbal intelligence and which ones to structural language.
- Open Access
- 5 June 2024
- Published by Wiley in Journal of Clinical Psychology
- Vol. 80 (9) , 2063-2076
Environmental and psychopathological predictors of clinical high‐risk of psychosis in adolescence
Objectives: Clinical high‐risk of psychosis (CHRp) samples can be heterogeneous, consisting essentially of people with not only psychotic‐like experiences but also nonspecific symptoms that may reflect common mental disorders such as depression, anxiety, or substance abuse pathologies. Few studies have attempted to analyze and understand psychosis risk in relation to both environmental (ER) and psychopathological risk (PsR) factors. This study aimed to determine the clinical risk of psychosis in adolescents.Methods: A representative sample of 1824 Spanish adolescents from the general population was evaluated using different scales to thoroughly examine the possible interaction of CHRp with various ER and PsR factors. Partial correlations were calculated to assess the relationships between the variables. A series of hierarchical linear regression models were then used to obtain a CHRp predictor model.Results: The CHRp predictor model indicated that PsR was the most significant determining factor, explaining 22% of the total associated variance of CHRp. However, the ER factor also emerged as a significant predictor of high‐risk psychosis (accounting for 9% of the variance).Conclusions: A predictive model for CHRp in adolescents was found, in which common psychological problems were presented as more determinant risk factors than ER disruptors. Furthermore, certain transdiagnostic processes, such as psychological inflexibility, may play a central role in the development of mental health problems, including psychosis. Specifying the mechanisms underlying the emergence of CHRp in adolescence is the key to optimizing the focus of preventive therapeutic interventions in these early stages.
- 5 June 2024
- Published by Wiley in Journal of Clinical Psychology
- Vol. 80 (9) , 2063-2076
Open AccessEnvironmental and psychopathological predictors of clinical high‐risk of psychosis in adolescence
Objectives: Clinical high‐risk of psychosis (CHRp) samples can be heterogeneous, consisting essentially of people with not only psychotic‐like experiences but also nonspecific symptoms that may reflect common mental disorders such as depression, anxiety, or substance abuse pathologies. Few studies have attempted to analyze and understand psychosis risk in relation to both environmental (ER) and psychopathological risk (PsR) factors. This study aimed to determine the clinical risk of psychosis in adolescents.Methods: A representative sample of 1824 Spanish adolescents from the general population was evaluated using different scales to thoroughly examine the possible interaction of CHRp with various ER and PsR factors. Partial correlations were calculated to assess the relationships between the variables. A series of hierarchical linear regression models were then used to obtain a CHRp predictor model.Results: The CHRp predictor model indicated that PsR was the most significant determining factor, explaining 22% of the total associated variance of CHRp. However, the ER factor also emerged as a significant predictor of high‐risk psychosis (accounting for 9% of the variance).Conclusions: A predictive model for CHRp in adolescents was found, in which common psychological problems were presented as more determinant risk factors than ER disruptors. Furthermore, certain transdiagnostic processes, such as psychological inflexibility, may play a central role in the development of mental health problems, including psychosis. Specifying the mechanisms underlying the emergence of CHRp in adolescence is the key to optimizing the focus of preventive therapeutic interventions in these early stages.
- Open Access
- 30 October 2023
- Published by Asociacion Espanola de Psiquiatria del Nino y del Adolescente - Aepnya in Revista de Psiquiatría Infanto-Juvenil
- Vol. 40 (4) , 17-29
Estudio observacional comparativo de un año de duración del impacto de la pandemia por COVID-19 en el desarrollo de síntomas de ansiedad y de depresión entre 100 niños y adolescentes en tratamiento en una Unidad de Salud Mental y 93 voluntarios sanos
La pandemia por COVID-19 ha generado una preocupación creciente por su posible impacto en la salud mental de niños y adolescentes. En este estudio hemos comparado la presencia de síntomas de ansiedad y de depresión en una muestra de 100 niños y adolescentes en tratamiento en una Unidad de Salud Mental Infanto-Juvenil y 93 voluntarios sanos durante el primer año desde el inicio de la pandemia COVID-19. Asimismo, hemos analizado si la edad o el sexo podrían actuar como factores de riesgo para el desarrollo de estos síntomas en ambos grupos. Los resultados obtenidos sugieren que las mujeres adolescentes con antecedentes de problemas relacionados con la salud mental son las personas más vulnerables para desarrollar síntomas de ansiedad y depresión durante una crisis sanitaria, como la pandemia por COVID-19, y, por lo tanto, tenerlas en cuenta en los programas de detección, prevención e intervención precoz que se lleven a cabo.
- 30 October 2023
- Published by Asociacion Espanola de Psiquiatria del Nino y del Adolescente - Aepnya in Revista de Psiquiatría Infanto-Juvenil
- Vol. 40 (4) , 17-29
Open AccessEstudio observacional comparativo de un año de duración del impacto de la pandemia por COVID-19 en el desarrollo de síntomas de ansiedad y de depresión entre 100 niños y adolescentes en tratamiento en una Unidad de Salud Mental y 93 voluntarios sanos
La pandemia por COVID-19 ha generado una preocupación creciente por su posible impacto en la salud mental de niños y adolescentes. En este estudio hemos comparado la presencia de síntomas de ansiedad y de depresión en una muestra de 100 niños y adolescentes en tratamiento en una Unidad de Salud Mental Infanto-Juvenil y 93 voluntarios sanos durante el primer año desde el inicio de la pandemia COVID-19. Asimismo, hemos analizado si la edad o el sexo podrían actuar como factores de riesgo para el desarrollo de estos síntomas en ambos grupos. Los resultados obtenidos sugieren que las mujeres adolescentes con antecedentes de problemas relacionados con la salud mental son las personas más vulnerables para desarrollar síntomas de ansiedad y depresión durante una crisis sanitaria, como la pandemia por COVID-19, y, por lo tanto, tenerlas en cuenta en los programas de detección, prevención e intervención precoz que se lleven a cabo.
- Open Access
- 16 August 2022
- Published by Royal College of Psychiatrists in European Psychiatry
- Vol. 65 (1) , 1-30
Pattern of long-term weight and metabolic changes after a first episode of psychosis: Results from a 10-year prospective follow-up of the PAFIP program for early intervention in psychosis cohort
Background: People with psychosis are at higher risk of cardiovascular events, partly explained by a higher predisposition to gain weight. This has been observed in studies on individuals with a first-episode psychosis (FEP) at short and long term (mainly up to 1 year) and transversally at longer term in people with chronic schizophrenia. However, there is scarcity of data regarding longer-term (above 3-year follow-up) weight progression in FEP from longitudinal studies. The aim of this study is to evaluate the longer-term (10 years) progression of weight changes and related metabolic disturbances in people with FEP. Methods: Two hundred and nine people with FEP and 57 healthy participants (controls) were evaluated at study entry and prospectively at 10-year follow-up. Anthropometric, clinical, and sociodemographic data were collected. Results: People with FEP presented a significant and rapid increase in mean body weight during the first year of treatment, followed by less pronounced but sustained weight gain over the study period (Δ15.2 kg; SD 12.3 kg). This early increment in weight predicted longer-term changes, which were significantly greater than in healthy controls (Δ2.9 kg; SD 7.3 kg). Weight gain correlated with alterations in lipid and glycemic variables, leading to clinical repercussion such as increments in the rates of obesity and metabolic disturbances. Sex differences were observed, with women presenting higher increments in body mass index than men. Conclusions: This study confirms that the first year after initiating antipsychotic treatment is the critical one for weight gain in psychosis. Besides, it provides evidence that weight gain keep progressing even in the longer term (10 years), causing relevant metabolic disturbances.
- 16 August 2022
- Published by Royal College of Psychiatrists in European Psychiatry
- Vol. 65 (1) , 1-30
Open AccessPattern of long-term weight and metabolic changes after a first episode of psychosis: Results from a 10-year prospective follow-up of the PAFIP program for early intervention in psychosis cohort
Background: People with psychosis are at higher risk of cardiovascular events, partly explained by a higher predisposition to gain weight. This has been observed in studies on individuals with a first-episode psychosis (FEP) at short and long term (mainly up to 1 year) and transversally at longer term in people with chronic schizophrenia. However, there is scarcity of data regarding longer-term (above 3-year follow-up) weight progression in FEP from longitudinal studies. The aim of this study is to evaluate the longer-term (10 years) progression of weight changes and related metabolic disturbances in people with FEP. Methods: Two hundred and nine people with FEP and 57 healthy participants (controls) were evaluated at study entry and prospectively at 10-year follow-up. Anthropometric, clinical, and sociodemographic data were collected. Results: People with FEP presented a significant and rapid increase in mean body weight during the first year of treatment, followed by less pronounced but sustained weight gain over the study period (Δ15.2 kg; SD 12.3 kg). This early increment in weight predicted longer-term changes, which were significantly greater than in healthy controls (Δ2.9 kg; SD 7.3 kg). Weight gain correlated with alterations in lipid and glycemic variables, leading to clinical repercussion such as increments in the rates of obesity and metabolic disturbances. Sex differences were observed, with women presenting higher increments in body mass index than men. Conclusions: This study confirms that the first year after initiating antipsychotic treatment is the critical one for weight gain in psychosis. Besides, it provides evidence that weight gain keep progressing even in the longer term (10 years), causing relevant metabolic disturbances.
- 6 July 2022
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 153, 292-299
Naturalistic study on the use of clozapine in the early phases of non-affective psychosis: A 10-year follow-up study in the PAFIP-10 cohort
- 6 July 2022
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 153, 292-299
Naturalistic study on the use of clozapine in the early phases of non-affective psychosis: A 10-year follow-up study in the PAFIP-10 cohort
- 1 February 2021
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 134, 150-157
Active psychosis and pro-inflammatory cytokines in first-episode of psychosis
- 1 February 2021
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 134, 150-157
Active psychosis and pro-inflammatory cytokines in first-episode of psychosis
- Open Access
- 27 August 2020
- Published by Springer Nature in Research Square
Expression and functionality study of 9 Toll-like receptors in drug-naïve non-affective first episode psychosis individuals: a 3-month study
The authors have withdrawn this preprint due to author disagreement.
- 27 August 2020
- Published by Springer Nature in Research Square
Open AccessExpression and functionality study of 9 Toll-like receptors in drug-naïve non-affective first episode psychosis individuals: a 3-month study
The authors have withdrawn this preprint due to author disagreement.
- Open Access
- 25 August 2020
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (17) , 6106
Expression and Functionality Study of 9 Toll-Like Receptors in 33 Drug-Naïve Non-Affective First Episode Psychosis Individuals: A 3-Month Study
Toll-like receptors (TLRs) are a pivotal component of the innate immune system that seem to have a role in the pathogenesis of psychosis. The purpose of this work was to compare the expression and functionality of 9 TLRs in three peripheral blood mononuclear cells (PBMCs) (monocytes, B cells, and T cells) between 33 drug-naïve first-episode psychosis (FEP) individuals and 26 healthy volunteers, at baseline and after 3-month of antipsychotic treatment. The expression of TLRs 1–9 were assessed by flow cytometry. For the assessment of the TLR functionality, cells collected in sodium heparin tubes were polyclonally stimulated for 18 h, with different agonists for human TLR1–9. The results of our study highlight the role that TLR5 and TLR8 might play in the pathophysiology of psychosis. We found a lower expression of these receptors in FEP individuals, regarding healthy volunteers at baseline and after 3-month of treatment on the three PBMCs subsets. Most TLRs showed a lower functionality (especially reduced intracellular levels of TNF-α) in patients than in healthy volunteers. These results, together with previous evidence, suggest that individuals with psychosis might show a pattern of TLR expression that differs from that of healthy volunteers, which could vary according to the intensity of immune/inflammatory response.
- 25 August 2020
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (17) , 6106
Open AccessExpression and Functionality Study of 9 Toll-Like Receptors in 33 Drug-Naïve Non-Affective First Episode Psychosis Individuals: A 3-Month Study
Toll-like receptors (TLRs) are a pivotal component of the innate immune system that seem to have a role in the pathogenesis of psychosis. The purpose of this work was to compare the expression and functionality of 9 TLRs in three peripheral blood mononuclear cells (PBMCs) (monocytes, B cells, and T cells) between 33 drug-naïve first-episode psychosis (FEP) individuals and 26 healthy volunteers, at baseline and after 3-month of antipsychotic treatment. The expression of TLRs 1–9 were assessed by flow cytometry. For the assessment of the TLR functionality, cells collected in sodium heparin tubes were polyclonally stimulated for 18 h, with different agonists for human TLR1–9. The results of our study highlight the role that TLR5 and TLR8 might play in the pathophysiology of psychosis. We found a lower expression of these receptors in FEP individuals, regarding healthy volunteers at baseline and after 3-month of treatment on the three PBMCs subsets. Most TLRs showed a lower functionality (especially reduced intracellular levels of TNF-α) in patients than in healthy volunteers. These results, together with previous evidence, suggest that individuals with psychosis might show a pattern of TLR expression that differs from that of healthy volunteers, which could vary according to the intensity of immune/inflammatory response.
- 1 December 2018
- Published by Elsevier in Schizophrenia Research
- Vol. 202, 226-233
Comparison of the anti-inflammatory effect of aripiprazole and risperidone in 75 drug-naïve first episode psychosis individuals: A 3 months randomized study
- 1 December 2018
- Published by Elsevier in Schizophrenia Research
- Vol. 202, 226-233
Comparison of the anti-inflammatory effect of aripiprazole and risperidone in 75 drug-naïve first episode psychosis individuals: A 3 months randomized study